Skip to main content
. 2019 Mar 23;9(3):e024693. doi: 10.1136/bmjopen-2018-024693

Table 1.

Sociodemographic and clinical characteristics of the sample (N=32)

Variable
Gender, n (%)
 Men 8 (25)
 Women 24 (75)
Age, mean (SD) 31.91 (7.44)
Highest education, n (%)
 Primary school 1 (3.1)
 High school 6 (18.8)
 Bachelor’s degree 14 (43.8)
 Master’s degree 10 (31.2)
 Doctorate degree 1 (3.1)
Occupational status, n (%)
 Working, full time 9 (28.1)
 Working, part time 10 (31.2)
 Student 7 (21.9)
 Unemployed 5 (15.6)
 Disability pension 1 (3.1)
Years with BDD, mean (SD) 16.22 (9.10)
No of areas of concern, mean (SD) 12.16 (5.84)
Comorbid conditions, n (%)
 Major depressive disorder 10 (31.2)
 Panic disorder 2 (6.2)
 Social anxiety disorder 5 (15.6)
 Generalised anxiety disorder 5 (15.6)
Current medication, n (%)
 SSRI 2 (6.2)
 SNRI 3 (9.4)
 Benzodiazepines 1 (3.1)
 Stimulants 1 (3.1)
Previous psychological treatment, n (%) 25 (78.1)
 CBT 8 (32.0)
 PDT 2 (8.0)
 Non-specific counselling 12 (48.0)
 Religious counselling 1 (4.0)
 Unknown 2 (8.0)
Plastic surgery
 Previous plastic surgery, n (%) 13 (40.6)
 No of surgeries, mean (SD) 1.38 (2.46)
Nationality, n (%)
 American 12 (37.5)
 Swedish 7 (21.9)
 Indian 1 (3.1)
 Bulgarian 1 (3.1)
 Finnish 1 (3.1)
 English 4 (12.5)
 Serbian 1 (3.1)
 South Korean 1 (3.1)
 Irish 1 (3.1)
 Norwegian 1 (3.1)
 Sri Lankan 1 (3.1)
 Lithuanian 1 (3.1)
Dysmorphic Concerns Questionnaire, mean (SD) 15.63 (2.50)

BDD, body dysmorphic disorder; CBT, cognitive–behavioural therapy; PDT, psychodynamic therapy; SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.